REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $15.5B | +11.0% |
| Gross profit | $5.9B | +18.0% |
| Operating income | $3.8B | 0.0% |
| Net income | $4.3B | +5.1% |
| EPS | $40.46 | +6.3% |
| Free cash flow | $3.8B | +15.3% |